Skip to main content

Nicolas Ferreyros

Editorial
10/15/2018
The Community Oncology Alliance (COA) and Journal of Clinical Pathways (JCP) have joined in collaboration to keep JCP readers informed about news and research in the community oncology field, including available...
The Community Oncology Alliance (COA) and Journal of Clinical Pathways (JCP) have joined in collaboration to keep JCP readers informed about news and research in the community oncology field, including available...
The...
10/15/2018
Journal of Clinical Pathways
Editorial
04/16/2019
As proposals directed at reducing the cost of prescription drugs are being discussed at the national level, the Community Oncology Alliance (COA) has taken a closer look at the assertion that oncologists who...
As proposals directed at reducing the cost of prescription drugs are being discussed at the national level, the Community Oncology Alliance (COA) has taken a closer look at the assertion that oncologists who...
As...
04/16/2019
Journal of Clinical Pathways
Attend #COA2020 to Prepare for What’s Next in Community Oncology
Editorial
04/21/2020
Oncology is changing rapidly as models of care and reimbursement evolve. We have seen this firsthand with the rapid expansion of telehealth services to combat the COVID-19 (coronavirus) pandemic.  This challenge to...
Oncology is changing rapidly as models of care and reimbursement evolve. We have seen this firsthand with the rapid expansion of telehealth services to combat the COVID-19 (coronavirus) pandemic.  This challenge to...
...
04/21/2020
Journal of Clinical Pathways
Nicolas Ferreyros, Community Oncology Alliance.
Videos
11/15/2023
In this interview, Nicolas Ferreyros, managing director, Community Oncology Alliance, summarizes some of the latest developments from Washington that are impacting cancer care and providers in community oncology.
In this interview, Nicolas Ferreyros, managing director, Community Oncology Alliance, summarizes some of the latest developments from Washington that are impacting cancer care and providers in community oncology.
In this interview, Nicolas...
11/15/2023
Cancer Care Business Exchange
Editorial
11/18/2018
The Oncology Care Model (OCM) is a federal health reform program that aims to change the way cancer care in America is delivered. Its goal? To provide high quality, well-coordinated cancer care to patients while...
The Oncology Care Model (OCM) is a federal health reform program that aims to change the way cancer care in America is delivered. Its goal? To provide high quality, well-coordinated cancer care to patients while...
The...
11/18/2018
Journal of Clinical Pathways
Editorial
02/19/2019
The 2019 Community Oncology Conference will focus on ensuring quality, affordable, and accessible cancer care. This will include 2 days full of learning and networking with community oncology practices and allied...
The 2019 Community Oncology Conference will focus on ensuring quality, affordable, and accessible cancer care. This will include 2 days full of learning and networking with community oncology practices and allied...
The...
02/19/2019
Journal of Clinical Pathways
COA Viewpoint
10/01/2024
This column discusses the growing movement for pharmacy benefit manager (PBM) reform and the latest developments from the US Congress to protect patients from PBM abuses.
This column discusses the growing movement for pharmacy benefit manager (PBM) reform and the latest developments from the US Congress to protect patients from PBM abuses.
This column discusses the...
10/01/2024
Journal of Clinical Pathways
COA Viewpoint
09/19/2023
Nicolas Ferreyros discusses the impact, or the lack of impact, the launch of the Enhancing Oncology Model has had on practices.
Nicolas Ferreyros discusses the impact, or the lack of impact, the launch of the Enhancing Oncology Model has had on practices.
Nicolas Ferreyros discusses the...
09/19/2023
Journal of Clinical Pathways
COA Viewpoint
06/05/2023
Nicolas Ferreyos from the Community Oncology Alliance discusses the Strengthening Medicare for Patients and Providers Act (HR 2474) and what it means for both physicians and patients on Medicare.
Nicolas Ferreyos from the Community Oncology Alliance discusses the Strengthening Medicare for Patients and Providers Act (HR 2474) and what it means for both physicians and patients on Medicare.
Nicolas Ferreyos from the...
06/05/2023
Journal of Clinical Pathways
COA Viewpoint
11/16/2021
Nicolas Ferreyros discusses the 340B Drug Discount Program and explains changes that need to be made in order to help vulnerable patients with cancer.
Nicolas Ferreyros discusses the 340B Drug Discount Program and explains changes that need to be made in order to help vulnerable patients with cancer.
Nicolas Ferreyros discusses the...
11/16/2021
Journal of Clinical Pathways